ArticleThe Lancet. Oncology2019
Endpoint selection in HER2-positive early breast cancer.
Eitan AmirPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2019
Eitan AmirPubMed ↗Publisher ↗
No numbers read from the abstract.